4Rein M S, Barbieri R L, Friedman A J. Progesterone : a critical role in the pathogenesis of uterine myomas[ J]. Am J Obstet Gynecol, 1995,172 ( 1 pt 1 ) : 14-18.
5Murphy A A, Kettel L M, Morales A J, et al. Regression of uterine leiomyomata in response to the antiprogesterone RU 486 [ J ]. J Clin Endocrinol M etab, 1993,76 ( 3 ) : 513- 517.
6Giudice L C, Irwin I C, Dsupin B A, et al. Insulin-like growth factor( IGF), IGF binding protein ( IGFBP ), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomatal J 1- Hum Reprod, 1993,8 ( 11 ) : 1796-1806.
7Yeh J, Rein M, Nowak R. Prosence of messenger ribonucleic acid for epidermal growth factor(EGF) and EGF receptor demonstrable in monolayer cell cultures of mymoetria and leiomyomata [ J ]. Fetil Steril, 1991,56 (50) :997-1000.
8Roseff S J, Kettel L M, Rivier J, et al. Accelerated dissolution of luteal-endometrial intergrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women[J]. Fertil Steril,1990,54(5) :805-810.
9Croxatto H B, Salvatierra A M, Romero C, et al. Late luteal phase administration of RU456 for three successive cycles does not disrupt bleeding patterns or ovulation[ J]. J Clin Endocrinol Metab, 1987,65 (6) : 1272-1276.
10Shortle B, Dyrenfurth I, Ferin M, et al. Effects of an antiproges- terone, agent RU486, on the menstrual cycle of the rhesus monkey[ J ]. J Clin Endocrinol Metab, 1985,60 (4) :731-735.
